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ABSTRACT We report here the first near-complete genome sequence (7,551 nucle-
otides) of a human norovirus GII.Pe-GII.4 Sydney variant, detected in a stool sample
from an outbreak on a cruise ship in 2013.
Human noroviruses have been identified as the primary cause of acute viral gas-troenteritis worldwide (1). Among the more than 30 genotypes that cause disease
in humans, GII.4 viruses have been reported to cause the majority of norovirus
infections worldwide (2, 3). New GII.4 variants have emerged every 2 to 3 years,
displacing previous dominant strains (4). GII.Pe.-GII.4 Sydney variant emerged in late
2012 (5) and accounted for 53% of the outbreaks in the United States from September
to December 2012 (6). In 2015, a new GII.4 Sydney variant (GII.P16-GII.4 Sydney
[KX907727]) emerged, which in the 2016 –2017 season is replacing GII.Pe-GII.4 Sydney
as the predominant outbreak strain (http://www.cdc.gov/norovirus/reporting/calicinet/
data.html). However, there is no complete genome sequence of GII.Pe-GII.4 Sydney
from the United States available in GenBank. We report here the first near-complete
genome sequence of a human norovirus GII.Pe-GII.4 Sydney, detected in a stool sample
associated with an outbreak on a cruise ship.
Viral RNA was extracted from the supernatant of a 10% (wt/vol) norovirus-positive
stool sample in phosphate-buffered saline using a QIAamp Viral RNA mini kit (Qiagen),
followed by library construction using a TruSeq mRNA library prep kit (Illumina) and
sequencing on the MiSeq platform (Illumina). Data were analyzed using CLC Genomics
Workbench (CLC bio). One contig covering the norovirus genome sequence was
assembled from 5,165,549 reads containing an average coverage of 66,490.
The near-complete (lack of 5= untranslated region [UTR] of 5 nucleotides [nt])
genome sequence was 7,551 nt in length and contained (i) three open reading frames
[ORFs]: ORF1, ORF2, and ORF3 of 5,094, 1,623, and 807 nt in length, respectively; and
(ii) a 3= UTR of 48 nt in length. The sequence could be typed as GII.Pe-GII.4 Sydney by
using the Norovirus Genotyping tool (7). A BLAST search confirmed that this sequence
shares 99% (7,448/7,540) nucleotide similarity with the prototype GII.4 Sydney 2012
strain (GenBank accession no. JX459908.1).
Adding an additional near-complete genome sequence of a GII.Pe-GII.4 Sydney
variant provides an additional reference sequence for phylogenetic and evolutionary
studies aimed at better understanding the mutation frequency of GII.4 variant strains.
Accession number(s). The genome sequence of the GII.Pe-GII.4 Sydney variant/USA
has been deposited in GenBank under the accession number KY486271.
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